C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism

ABSTRACT Obesity is a risk factor for cardiovascular disease. C1q/tumor necrosis factor-related protein 9 (CTRP9) is an adipokine that is downregulated by obesity. We investigated the role of CTRP9 in cardiac injury with loss-of-function genetic manipulations and defined the receptor-mediated signaling pathway downstream of this adipokine. CTRP9-knockout (CTRP9-KO) mice at the age of 12 weeks were indistinguishable from wild-type (WT) mice under basal conditions. CTRP9-KO mice had exacerbated contractile left ventricle dysfunction following intraperitoneal injection of lipopolysaccharide (LPS) compared to WT mice. Administration of LPS to CTRP9-KO mice also resulted in increased expression of proinflammatory cytokines and oxidative stress markers in the heart compared to WT mice. Likewise, CTRP9-KO mice showed increased myocardial infarct size and elevated expression of inflammatory mediators in ischemic heart following ischemia and reperfusion compared to WT mice. Treatment of cardiac myocytes with CTRP9 protein led to suppression of LPS-induced expression of proinflammatory genes, which was reversed by blockade of AMPK or ablation of adiponectin receptor I (AdipoR1). Systemic delivery of CTRP9 attenuated LPS-induced cardiac dysfunction in WT mice but not in muscle-specific transgenic mice expressing dominant-negative mutant form of AMPK or in AdipoR1-knockout mice. CTRP9 protects against acute cardiac damage in response to pathological stimuli by suppressing inflammatory reactions through AdipoR1/AMPK-dependent mechanisms.

[1]  S. Kihara,et al.  Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin , 2004, Circulation research.

[2]  B. Fisslthaler,et al.  Activation and signaling by the AMP-activated protein kinase in endothelial cells. , 2009, Circulation research.

[3]  K. Komori,et al.  Adiponectin Ameliorates Endotoxin-Induced Acute Cardiac Injury , 2014, BioMed research international.

[4]  Yajing Wang,et al.  C1q/Tumor Necrosis Factor–Related Protein-9, a Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling in the Ischemic Mouse Heart via Protein Kinase A Activation , 2013, Circulation.

[5]  T. Murohara,et al.  Therapeutic Impact of Follistatin-Like 1 on Myocardial Ischemic Injury in Preclinical Models , 2012, Circulation.

[6]  G. Su,et al.  Resveratrol Alleviates Endotoxin-Induced Myocardial Toxicity via the Nrf2 Transcription Factor , 2013, PloS one.

[7]  T. Murohara,et al.  CTRP9 Protein Protects against Myocardial Injury following Ischemia-Reperfusion through AMP-activated Protein Kinase (AMPK)-dependent Mechanism* , 2012, The Journal of Biological Chemistry.

[8]  H. Lodish,et al.  Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  T. Murohara,et al.  Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model. , 2015, Journal of the American Society of Nephrology : JASN.

[10]  Robert Wolk,et al.  Body Mass Index: A Risk Factor for Unstable Angina and Myocardial Infarction in Patients With Angiographically Confirmed Coronary Artery Disease , 2003, Circulation.

[11]  A. F. Stewart,et al.  High-throughput engineering of the mouse genome coupled with high-resolution expression analysis , 2003, Nature Biotechnology.

[12]  Y. Hwang,et al.  Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans , 2014, International Journal of Obesity.

[13]  D. Hardie,et al.  Metabolism of inflammation limited by AMPK and pseudo-starvation , 2013, Nature.

[14]  D. Labarthe,et al.  The Relation of Diabetes to the Severity of Acute Myocardial Infarction and Post-Myocardial Infarction Survival in Mexican-Americans and Non-Hispanic Whites: The Corpus Christi Heart Project , 1994, Diabetes.

[15]  S. Kihara,et al.  Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[16]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[17]  M. Entman,et al.  The inflammatory response in myocardial infarction. , 2002, Cardiovascular research.

[18]  L. Kirshenbaum,et al.  Multiple facets of NF-κB in the heart: to be or not to NF-κB. , 2011, Circulation Research.

[19]  Yajing Wang,et al.  C1q/TNF-Related Proteins, A Family of Novel Adipokines, Induce Vascular Relaxation Through the Adiponectin Receptor-1/AMPK/eNOS/Nitric Oxide Signaling Pathway , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[20]  P. W. Wilson,et al.  The Relation , 2009 .

[21]  M. Seldin,et al.  CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[22]  S. Kihara,et al.  Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.

[23]  T. Murohara,et al.  The potential of adipokines as therapeutic agents for cardiovascular disease. , 2014, Cytokine & growth factor reviews.

[24]  G. W. Wong,et al.  Targeted deletion of C1q/TNF-related protein 9 increases food intake, decreases insulin sensitivity, and promotes hepatic steatosis in mice. , 2014, American journal of physiology. Endocrinology and metabolism.

[25]  M. Bucan,et al.  A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. , 2001, Molecular cell.

[26]  NoriyukiOuchi,et al.  Selective Suppression of Endothelial Cell Apoptosis by the High Molecular Weight Form of Adiponectin , 2004 .

[27]  Kazuto Nakamura,et al.  Divergent Roles for Adiponectin Receptor 1 (AdipoR1) and AdipoR2 in Mediating Revascularization and Metabolic Dysfunction in Vivo* , 2014, The Journal of Biological Chemistry.

[28]  K. Walsh,et al.  Cardiovascular and metabolic regulation by the adiponectin/C1q/tumor necrosis factor-related protein family of proteins. , 2012, Circulation.

[29]  T. Peng,et al.  Pivotal Role of gp91phox-Containing NADH Oxidase in Lipopolysaccharide-Induced Tumor Necrosis Factor-α Expression and Myocardial Depression , 2005, Circulation.

[30]  T. Murohara,et al.  Adipose‐derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.